Stakeholder readiness in the evolving adult vaccine market

The adult vaccine market is undergoing rapid transformation, driven by an aging population and advancements in vaccine technology post-COVID. Research conducted in June 2022 highlights divergent stakeholder perspectives; policy makers and purchasers underestimate emerging challenges, while immunizers and consumers express concern about the increasingly complex vaccine landscape. Findings from over 750 participants reveal the need for strategic efforts to manage the integration of new vaccines and streamline communication among stakeholders. The study emphasizes improving data interoperability and adapting infrastructure, particularly through retail pharmacies, to meet rising demand. Collaborative efforts are critical to addressing bottlenecks and stakeholder overwhelm, ensuring a resilient vaccination ecosystem. This research provides actionable insights for navigating the evolving market and fostering success in a challenging era.

Authors

Institutions

Publication Details

Journal
iScience
Published
2025-08-18
DOI
https://doi.org/10.1016/j.isci.2025.113385
Primary Topic
Vaccine Coverage and Hesitancy
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stakeholder readiness in the evolving adult vaccine market

Charles H. Jones, Verna Welch, Matthew P. Jenkins, Anthony F. Hill et al.
iScience
Vaccine Coverage and Hesitancy
article

Stakeholder readiness in the evolving adult vaccine market

Charles H. Jones, Verna Welch, Matthew P. Jenkins, Anthony F. Hill, Jane M. True, Antonietta F Forte
article en

Abstract

The adult vaccine market is undergoing rapid transformation, driven by an aging population and advancements in vaccine technology post-COVID. Research conducted in June 2022 highlights divergent stakeholder perspectives; policy makers and purchasers underestimate emerging challenges, while immunizers and consumers express concern about the increasingly complex vaccine landscape. Findings from over 750 participants reveal the need for strategic efforts to manage the integration of new vaccines and streamline communication among stakeholders. The study emphasizes improving data interoperability and adapting infrastructure, particularly through retail pharmacies, to meet rising demand. Collaborative efforts are critical to addressing bottlenecks and stakeholder overwhelm, ensuring a resilient vaccination ecosystem. This research provides actionable insights for navigating the evolving market and fostering success in a challenging era.

iScienceVol. 28(9)
Pfizer (United States) (US)
Pfizer
Openalex Percentile: Top 74%
Vaccine Coverage and Hesitancy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.